ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 185 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,694,000 | -9.1% | 940,000 | 0.0% | 1.42% | -17.0% |
| Q3 2016 | $12,869,000 | +62.0% | 940,000 | -12.6% | 1.71% | +62.1% |
| Q2 2016 | $7,944,000 | +15.7% | 1,075,000 | 0.0% | 1.06% | +9.3% |
| Q1 2016 | $6,869,000 | +34.0% | 1,075,000 | +31.1% | 0.96% | +52.7% |
| Q4 2015 | $5,125,000 | +22.5% | 820,000 | +14.4% | 0.63% | +1.1% |
| Q3 2015 | $4,184,000 | -8.0% | 716,500 | +30.3% | 0.62% | +4.5% |
| Q2 2015 | $4,549,000 | +0.4% | 550,000 | 0.0% | 0.60% | -0.3% |
| Q1 2015 | $4,532,000 | – | 550,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |